Continued strong Cresemba® (isavuconazole) sales trigger second sales milestone this year from Pfizer to Basilea of USD 7 million

 

Continued strong Cresemba® (isavuconazole) sales trigger second sales milestone this year from Pfizer to Basilea of USD 7 million

future events or otherwise. SHARE THIS POST Basilea Pharmaceutica NewsMORE your MARKET VIEW Related Stocks Find News …

More Continued strong Cresemba® (isavuconazole) sales trigger second sales milestone this year from Pfizer to Basilea of USD 7 million Videos

Leave a Reply